{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:24:36Z","timestamp":1779927876150,"version":"3.53.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul University","doi-asserted-by":"publisher","award":["46524"],"award-info":[{"award-number":["46524"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.trim.2026.102361","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:21:20Z","timestamp":1770657680000},"page":"102361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparison of Total Leukocyte Chimerism and Lymphocyte Subset Chimerism for Early Detection of Post-Transplant Complications"],"prefix":"10.1016","volume":"95","author":[{"given":"Metban","family":"Mastanzade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Abatay Sel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek","family":"Y\u00f6nal Hindilerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Duvarc\u0131 \u00d6\u011fret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meliha","family":"Nal\u00e7ac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Savran O\u011fuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Kalayo\u011flu Be\u015f\u0131\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trim.2026.102361_bb0005","first-page":"118","article-title":"Factors influencing overall survival and GvHD development after allogeneic hematopoietic stem cell transplantation - single centre experience","volume":"38","author":"Homolov\u00e1","year":"2024","journal-title":"Klin. Onkol."},{"key":"10.1016\/j.trim.2026.102361_bb0010","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3389\/fimmu.2020.01854","article-title":"Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2026.102361_bb0015","article-title":"The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2026.102361_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1274492","article-title":"Low-dose decitabine-intensified modified conditioning regimen alleviates aGVHD in AML\/MDS patients treated with allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2026.102361_bb0025","first-page":"1","article-title":"UK best practice recommendations for chimerism testing following haematopoietic stem cell transplantation","volume":"200","author":"British Society for Haematology","year":"2025","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.trim.2026.102361_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052811","article-title":"Utility of next-generation sequencing-based chimerism analysis for early relapse prediction following allogenic hematopoietic cell transplantation","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.trim.2026.102361_bb0035","first-page":"43","article-title":"Chimerism monitoring by short tandem repeat (STR) markers in allogeneic hematopoietic stem cell transplantation: a review","volume":"26","author":"Dumache","year":"2018","journal-title":"Roman. J. Legal Med."},{"issue":"2","key":"10.1016\/j.trim.2026.102361_bb0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbmt.2018.09.004","article-title":"Peripheral blood versus bone marrow from unrelated donors: bone marrow allografts have improved long-term overall and graft-versus-host disease-free, relapse-free survival","volume":"25","author":"Alousi","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"28","key":"10.1016\/j.trim.2026.102361_bb0045","first-page":"3228","article-title":"Bone marrow versus peripheral blood as a graft source for haploidentical transplantation using post-transplant cyclophosphamide: a study on behalf of the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party","volume":"38","author":"Battipaglia","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.trim.2026.102361_bb0050","first-page":"1231","article-title":"HLA-matched sibling versus unrelated versus haploidentical related donors for allogeneic hematopoietic cell transplantation in AML patients aged \u2265 60 years","volume":"24","author":"Devillier","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.trim.2026.102361_bb0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jtct.2021.04.017","article-title":"Comparison of myeloablative versus reduced-intensity conditioning regimens in allogeneic stem cell transplant recipients with acute myelogenous leukemia","volume":"27","author":"Yu","year":"2021","journal-title":"Transplant. Cell. Ther."},{"issue":"1","key":"10.1016\/j.trim.2026.102361_bb0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood-2021-147052","article-title":"HLA-matched related hematopoietic stem cell transplantation in adolescents and adults with sickle cell disease: comparison of myeloablative versus non myeloablative approaches","volume":"138","author":"Dh\u00e9din","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.trim.2026.102361_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.12055","article-title":"AA genotype of single-nucleotide polymorphism c. 834+ 7 G> a in GAS 6 gene (rs8191974) is not protective for acute myocardial infarction","volume":"35","author":"Jambou","year":"2013","journal-title":"Int. J. Lab. Hematol."},{"issue":"4","key":"10.1016\/j.trim.2026.102361_bb0070","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/jha2.568","article-title":"Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis","volume":"3","author":"Lindahl","year":"2022","journal-title":"EJHaem"},{"key":"10.1016\/j.trim.2026.102361_bb0075","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jcma.2018.06.005","article-title":"Early achievement of full donor chimerism after allogeneic hematopoietic stem cell transplantation predicts lower relapse risk in patients with acute lymphoblastic leukemia","volume":"81","author":"Chen","year":"2018","journal-title":"J. Chin. Med. Assoc."},{"issue":"1","key":"10.1016\/j.trim.2026.102361_bb0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.56875\/2589-0646.1112","article-title":"Is mixed chimerism post-allogeneic hematopoietic stem cell transplantation in pediatric acute lymphoid leukemia a prognostic factor for relapse?","volume":"17","author":"Khan","year":"2023","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"issue":"11","key":"10.1016\/j.trim.2026.102361_bb0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/cells13110993","article-title":"Prospects and potential for chimerism analysis after allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Miura","year":"2024","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.trim.2026.102361_bb0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1702504","article-title":"Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study","volume":"26","author":"Choi","year":"2000","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2026.102361_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajh.26042","article-title":"Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: the role of the conditioning regimen","volume":"96","author":"Chiusolo","year":"2021","journal-title":"Am. J. Hematol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:54:25Z","timestamp":1773291265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":19,"alternative-id":["S0966327426000195"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102361","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Total Leukocyte Chimerism and Lymphocyte Subset Chimerism for Early Detection of Post-Transplant Complications","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102361"}}